Sign up to hear about Events

Due to legal limitations on communicating prescription-only medicines directly to the general population, the primary application for advanced data analysis in German pharma communication is the targeted engagement of Healthcare Professionals (HCPs). This B2B approach leverages compliant data assets to optimize the professional exchange of medical information.

The Intelligence-Driven Interaction

Pharmaceutical and medical device companies utilize sophisticated data analysis to move beyond broad mailings and generic sales visits, focusing instead on relevance and personalized content delivery:

• Profiling and Segmentation: Data models analyze professional behaviors, including prescribing patterns (in aggregated form), clinical interests, digital content consumption (e.g., medical journal subscriptions, webinar attendance), and conference participation.

• The "Next Best Action": Analytical tools advise communication teams (including sales representatives) on the optimal channel (e.g., professional portal, encrypted email, or in-person visit), message, and timing for engagement, significantly improving the efficiency of information delivery.

• Evidence-Based Content: Communication is driven by scientific evidence and regulatory compliance, ensuring that physicians receive highly specific, relevant clinical data and trial results pertinent to their patient population and specialty.

This application ensures that valuable resources are focused on the most relevant medical experts, improving the utility of information shared within the healthcare ecosystem.